WO2008137161A2 - Concurrent electrophysiologic and cerebral blood flow neuroimaging - Google Patents

Concurrent electrophysiologic and cerebral blood flow neuroimaging Download PDF

Info

Publication number
WO2008137161A2
WO2008137161A2 PCT/US2008/005815 US2008005815W WO2008137161A2 WO 2008137161 A2 WO2008137161 A2 WO 2008137161A2 US 2008005815 W US2008005815 W US 2008005815W WO 2008137161 A2 WO2008137161 A2 WO 2008137161A2
Authority
WO
WIPO (PCT)
Prior art keywords
eeg
data
cbf
blood flow
asl
Prior art date
Application number
PCT/US2008/005815
Other languages
French (fr)
Other versions
WO2008137161A3 (en
Inventor
Jiongjiong Wang
Hengyi Rao
Original Assignee
The Trustees Of The University Of Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of The University Of Pennsylvania filed Critical The Trustees Of The University Of Pennsylvania
Publication of WO2008137161A2 publication Critical patent/WO2008137161A2/en
Publication of WO2008137161A3 publication Critical patent/WO2008137161A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0263Measuring blood flow using NMR
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/369Electroencephalography [EEG]
    • A61B5/372Analysis of electroencephalograms
    • A61B5/374Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4806Sleep evaluation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/0816Measuring devices for examining respiratory frequency
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis

Definitions

  • This invention is directed to methods for concurrently recording electrophysiologic signal (EEG) and cerebral blood flow (CBF) signal from human brain. Specifically, the invention relates to methods for noninvasively assessing brain function during a subject's sleep and its utility.
  • EEG electrophysiologic signal
  • CBF cerebral blood flow
  • radioisotope e.g., FDG
  • FDG radioisotope
  • EEG EEG and functional magnetic resonance imaging
  • fMRI functional magnetic resonance imaging
  • simultaneous EEG and (blood- oxygen-level-dependent) BOLD fMRI have been successfully applied for seizure localization in epilepsy patients.
  • concurrent EEG/BOLD fMRI cannot be directly applied for sleep research since BOLD fMRI is only able to image transient brain responses elicited by external stimuli and tasks.
  • removal of the large artifact in EEG signal caused by rapid magnetic gradient switching in BOLD fMRI is challenging, especially performed in real time.
  • Event-related potential (ERP) often has to be extracted from EEG for correlation with BOLD fMRI, whose magnitude is on the order of one tenth of the original EEG signal, adding further difficulty for signal processing.
  • ASL perfusion MRI is a noninvasive neuroimaging technique that offers absolute quantification of CBF both at rest and during task activation.
  • ASL is ideally suited for imaging sustained behavioral states due to its long term temporal stability.
  • Concurrent recording of EEG and ASL perfusion fMRI provides several potential advantages.
  • resting perfusion can be easily linked to EEG power spectrum during specific behavioral states without the need to perform task activation.
  • ASL scans include inherent magnetic gradient quiet periods (e.g., delay time) with reduced interferences for EEG recording, facilitating real-time noise removal.
  • EEG/ASL studies are less demanding in terms of signal processing, since ERP is generally not required.
  • EEG/ASL data can be continuously recorded across various stages of the sleep-wake cycle with a temporal resolution of seconds in one scanning session.
  • the acoustic noise level is also much lower in ASL than BOLD fMRI, which is a benefit for sleep neuroimaging.
  • Neuroimaging of sleep is well suited for concurrent EEG/ASL. Once reliable neuroimaging markers for various sleep stages are identified, the technique can be used for monitoring effects of pharmacological and behavioral manipulations on sleep. Ideally, because EEG and ASL perfusion MRI each provides unique markers for certain neurobiological processes, the fusion of the two technologies is expected to create more reliable neuroimaging markers than each technique alone. EEG/ASL is also expected to have wide applications outside sleep research, including assessing mental state/stress during continuous performance tasks, monitoring neurophysiological effects of drug candidates, and seizure localization etc.
  • the invention provides a method of neuroimaging brain function of a subject during sleep, comprising the steps of: Concurrently recording electrophysiologic brain signals and cerebral blood flow (CBF) data of the sleeping subject; Reconstructing the cerebral blood flow (CBF) data within time window of interest based on a marker of electrophysiologic brain signals; and Dynamically associating the electrophysiologic brain signals and reconstructed cerebral blood flow (CBF) data, thereby neuroimaging brain function of the subject during sleep.
  • CBF cerebral blood flow
  • a method of diagnosing or providing prognosis of sleep disorders or both in a subject comprising concurrently neuroimaging brain function of the subject during sleep using concurrent recording electrophysiologic brain signals and cerebral blood flow (CBF) data; comparing the data with a standard, whereby the standard is taken from a subject or pool of subject previously, correctly diagnosed as having the sleep disorder sought to be diagnosed or for which prognosis is given; and comparing the signals.
  • CBF cerebral blood flow
  • the invention provides a method of screening an agent for effectiveness as a sleeping aid in a subject, comprising concurrently neuroimaging brain function of the subject during sleep using concurrent recording electrophysiologic brain signals and cerebral blood flow (CBF) data; comparing the data with a standard, whereby the standard is taken from a subject or pool of subject previously exposed to an effective, or ineffective sleeping medication; and comparing the signals.
  • CBF cerebral blood flow
  • the invention provides a method of screening effects of stress on sleep in a subject, comprising concurrently neuroimaging brain function of the subject during sleep using concurrent recording electrophysiologic brain signals and cerebral blood flow (CBF) data; comparing the data with a standard, whereby the standard is taken from the subject before or after being exposed to the stress whose effect is sought to be screened.
  • CBF cerebral blood flow
  • Figure 2 shows an embodiment of a system for concurrent fMRI and EEG.
  • Figure 3 shows CBF activation differences between three states.
  • Figure 4 shows EEG spectral analysis of EC (red), EO (green), and MC (yellow) during BOLD fMRI and ASL fMRI scanning.
  • FIG. 5 shows diagram of ASL pulse sequences which consist of spin labeling, post-labeling delay time, image acquisition and delay time (TD); also shown are associated acoustic noise level and interferences on EEG recording.
  • the post-labeling delay and TD portions are silent periods in terms of magnetic gradient and acoustic noise, which do not interfere with EEG recording.
  • the labeling period causes mild interferences and mild acoustic noise, while only the imaging acquisition part generates high interferences on EEG and a high acoustic noise level due to the use of rapid imaging sequences such as the echo-planar imaging (EPI).
  • EPI echo-planar imaging
  • This invention relates in one embodiment to methods for concurrently recording electrophysiologic signal (EEG) and cerebral blood flow (CBF) signal from human brain.
  • the invention relates to methods for noninvasively assessing brain function using functional MRI and electroencephalograph (EEG).
  • the method provided herein are used for neuroimaging of sleep.
  • the methods provided herein are used for investigating the neurobiology of sleep along with the dynamic changes across the sleep-wake cycle.
  • Clinical applications of the methods described herein are diagnosis and prognosis of sleep disorders, or in another embodiment, testing central effects of sleep medications.
  • EEG and perfusion fMRI provide specific markers for work load, vigilance, stress and drug effects etc, the methods described herein are useful for monitoring continuous performance tasks, CNS responses to pharmacological manipulations, and bio-feedback training.
  • combination of EEG and fMRI offers the potential for multi-model neuroimaging with both high spatial and temporal resolutions.
  • a method of neuroimaging brain function of a subject during sleep comprising the steps of: Concurrently recording electrophysiologic brain signals and cerebral blood flow (CBF) data of the sleeping subject; Reconstructing the cerebral blood flow (CBF) data within time window of interest based on a marker of electrophysiologic brain signals; and Dynamically associating the electrophysiologic brain signals and reconstructed cerebral blood flow (CBF) data, thereby neuroimaging brain function of the subject during sleep.
  • concurrent EEG and perfusion fMRI is used for tracking gradual state changes in brain function (e.g. sleep), with characteristic markers in both hemodynamics and neurophysiology.
  • electrophysiologic brain signals are recorded using electroencephalography (EEG).
  • EEG electroencephalography
  • An "electroencephalogram” or “EEG” refers in one embodiment, to an outward indication of electrical activity from the most superficial layers of the cerebral cortex, usually recorded from electrodes on the scalp. This activity is the result of the rhythmic discharging of neurons under the electrode.
  • the EEG signal provides information about the frequency and amplitude of the neuronal electrical activity and its temporal variation, or in another embodiment, of electrophysiologic brain signals.
  • the EEG frequency spectrum comprises signals in a 2 to 80 Hz range, with most activity between about 2 and 15 Hz.
  • a linear analysis method such as a Fourier transform
  • a nonlinear analysis method such as a correlation dimension estimation.
  • the Fourier transform can obtain the information for a specific frequency component such as ⁇ -wave (8-13 Hz) and ⁇ -wave (14-30 Hz) extensively studied.
  • the correlation dimension estimation is used to determine whether or not EEG time series are chaos signals.
  • arterial spin labeling a particular MRI technology, termed arterial spin labeling
  • ASL Advanced Spin Labeling
  • This imaging provides perfusion (tissue blood) images in which blood vessels and microcirculation of a subject are reflected, without injecting contrast medium into the subject, i.e., non-invasively.
  • the ASL method used in the methods described herein includes a “continuous ASL (CASL) technique” or a “pulsed ASL (PASL) technique” or a “pseudo-continuous ASL technique”.
  • CASL technique refers in one embodiment, to a way of applying a largely continuous adiabatic RF wave
  • PASL technique refers to the application of a pulsed adiabatic RF wave that can easily be practiced by a clinical MRI system.
  • pseudo-continuous ASL technique refers to the application of a train of pulsed RF wave to simulate the effect of CASL.
  • cerebral blood flow is measured directly by using arterial blood water as an endogenous contrast agent.
  • perfusion MRI used in the methods as described herein is ideal for imaging a sustained behavioral state, such as sleep in another embodiment with excellent reproducibility over long-term time periods and minimal sensitivity to magnetic-field inhomogeneity effects, that involves the function of deep brain structures.
  • the brain regions used in the methods for tracking gradual state changes in brain function (e.g. sleep) with characteristic markers in both hemodynamics and neurophysiology a are the right prefrontal cortex (RPFC), left prefrontal cortex, orbitofrontal cortex, anterior cingulate cortex (ACC), insula,shiftan, amygdala, striatum, nucleus accumbens (NA) and hippocampus or a combination thereof.
  • RPFC right prefrontal cortex
  • ACC anterior cingulate cortex
  • insula,shiftan anterior cingulate cortex
  • amygdala striatum
  • the prefrontal cortex, dorsal striatum, and medial temporal lobe are involved in task completion under condition of sleep deprivation and are the brain regions monitored using the methods provided herein.
  • concurrent recording of EEG and ASL perfusion MRI involves the use of MRI compatible EEG systems during perfusion MRI scanning.
  • subjects wear an electrode cap made of non-magnetic material, and the EEG signal is conducted through fiberoptic cables or carbon fibers to amplifiers outside the MRI scan room.
  • Amplified EEG signal is stored in one embodiment and displayed in real time in another embodiment, by a PC workstation.
  • perfusion fMRI scanning utilizes ASL sequences
  • ASL sequence transmits a TTL pulse every measurement (TR) to the EEG workstation to synchronize the data stream in two modalities. If real time analysis of ASL data is required in one embodiment, the acquired perfusion MRI series is transferred from the MR host computer to the EEG workstation through network links on the fly. [00027] For sleep research, the acoustic noise of ASL image acquisition can be further reduced by several approaches.
  • physiological data that can be concurrently measured include heart rate, blood pressure, respiration rate, temperature, PaCO2, PaO2, and galvanic skin response (GSR).
  • GSR galvanic skin response
  • perfusion MRI series are loaded in one embodiment onto a common software platform together with EEG during post-processing or in real time in another embodiment.
  • MRI and EEG data are temporally aligned according to TTL markers.
  • Initial MRI data processes include exclusion of spurious spikes in one embodiment, or motion correction and spatial smoothing or their combination in other embodiments.
  • the user defines the time window of interest by evaluating continuous EEG data (e.g., REM) in certain embodiments, or according to other pre-selected triggers.
  • mean quantitative CBF maps of the defined time window are automatically generated (using ASL perfusion models), displayed and stored for further analysis.
  • the software is flexible enough to generate CBF maps for each time period, or to integrate over several discrete time windows, or to provide difference CBF maps between two periods.
  • ASL data is acquired through the use specific EEG markers as trigger to initiate ASL perfusion MRI scanning.
  • EEG and perfusion image series are carried out.
  • EEG power spectrum provides indices of slow and fast components (e.g. Delta vs. Beta) as a function of time, which are used in another embodiment as covariates in correlation analysis of the perfusion time series.
  • perfusion time series in specific brain regions are used as covariates in correlation analysis of the EEG time series.
  • the step of reconstruction of CBF data within time window of interest based on EEG markers in the methods of neuroimaging brain function of a subject during sleep is preceded by a step of removing noise of EEG data in real time.
  • EEG periods presenting gradient artifacts are masked.
  • the cardio-ballistic noise in EEG caused by involuntary subject movements is minimized by online regression with EKG signal.
  • the processed EEG signals have sufficient quality in one embodiment, for spotting characteristic marks for behavioral states (e.g., Delta wave, K complexes for slow wave sleep).
  • online noise removal is performed to further reduce the gradient artifacts during MRI scanning.
  • reducing the gradient artifacts during MRI scanning requires pre- scanning to generate a template of time-locked gradient induced EEG artifact, followied by subtracting this noise template from real time EEG data using statistical methods, such as principle component analysis in one embodiment, or least-squares based fitting and cluster analysis in other embodiments.
  • brain regions demonstrating CBF changes in ASL perfusion are presented in one embodiment.
  • MRI can be used as hypothesized foci of neural activation.
  • Simulated EEG data based on these detected activation loci (seeds) can be generated and compared with the observed EEG signals, providing a means to validate the neural network model associated with a specific behavioral state.
  • both EEG and ASL data can be correlated with behavioral performance and physiological signals such as heart rate, blood pressure etc.
  • the concurrently collected EEG/ASL data using the methods provided herein is displayed to subjects in real time as bio-feedback, while subjects are required to self-manipulate blood flow and electrophysiologic signals.
  • subject refers in one embodiment to a mammal including a human in need of therapy for, or susceptible to, a condition or its sequelae.
  • the subject may include dogs, cats, pigs, cows, sheep, goats, horses, rats, and mice and humans.
  • subject does not exclude an individual that is normal in all respects.
  • This step involves the use of MRI compatible EEG systems during perfusion MRI scanning.
  • Subjects wear an electrode cap made of non-magnetic material, and the EEG signal is conducted through fiberoptic cables or carbon fibers to amplifiers outside the MRI scan room.
  • Amplified EEG signal is then stored and displayed in real time by a PC workstation.
  • EEG sampling rate can be kept within 5kHz because of the low interference from ASL sequences.
  • Perfusion fMRI scanning utilizes ASL sequences (including pulsed, continuous and pseudo- continuous ASL), which generally comprise of three portions for spin labeling, delay time and image acquisition.
  • a relatively long repetition time (TR>4s) is used to ensure at least 50% of scan time is free of magnetic gradient artifact.
  • the ASL sequence transmits a TTL pulse every measurement (TR) to the EEG workstation to synchronize the data stream in two modalities. If real time analysis of ASL data is required, the acquired perfusion MRI series need to be transferred from the MR host computer to the EEG workstation through network links on the fly.
  • the acoustic noise of ASL image acquisition can be further reduced by several approaches. These approaches include adjusting the EPI-readout frequency to avoid the resonance frequencies of gradient coil vibrations, the use of quite gradient coils and silent MR pulse sequences. Due to the relatively long scan time for sleep research, the ASL sequences can further correct head motion in real time by incorporating techniques such as prospective acquisition correction. Additional physiological data that can be concurrently measured include heart rate, blood pressure, respiration rate, temperature, PaCO2, PaO2, and galvanic skin response (GSR).
  • GSR galvanic skin response
  • EEG is free of MRI artifact
  • the simplest approach is just to mask out those EEG periods presenting gradient artifacts.
  • the cardio-ballistic noise in EEG caused by involuntary subject movements is minimized by online regression with EKG signal.
  • These processed EEG signals have sufficient quality for spotting characteristic marks for behavioral states (e.g., Delta wave, K complexes for slow wave sleep).
  • online noise removal can be performed to further reduce the gradient artifacts during MRI scanning. This step requires pre- scanning to generate a template of time-locked gradient induced EEG artifact, and then subtract this noise template from real time EEG data using principle component analysis or least-squares based fitting. Reconstruction of CBF data within time window of interest based on EEG markers
  • the perfusion MRI series are loaded onto a common software platform together with EEG during post-processing or in real time.
  • the MRI and EEG data are temporally aligned according to TTL markers.
  • Initial MRI data processes include exclusion of spurious spikes, motion correction and spatial smoothing.
  • the user then can define the time window of interest by evaluating continuous EEG data (e.g., REM).
  • Mean quantitative CBF maps of the defined time window can be automatically generated (using ASL perfusion models), displayed and stored for further analysis.
  • the software is flexible enough to generate CBF maps for each time period, or to integrate over several discrete time windows, or to provide difference CBF maps between two periods.
  • An alternative approach to acquire ASL data is to use specific EEG markers as trigger to initiate ASL perfusion MRI scanning.
  • EEG power spectrum provides indices of slow and fast components (e.g. Delta vs. Beta) as a function of time, which are used as covariates in correlation analysis of the perfusion time series.
  • perfusion time series in specific brain regions are used as covariates in correlation analysis of the EEG time series.
  • brain regions demonstrating CBF changes in ASL perfusion MRI can be used as hypothesized foci of neural activation.
  • Simulated EEG data based on these detected activation loci (seeds) can be generated and compared with the observed EEG signals, providing a means to validate the neural network model associated with a specific behavioral state.
  • Both EEG and ASL data can be correlated with behavioral performance and physiological signals such as heart rate, blood pressure etc.
  • the EEG/ASL data can be displayed to subjects in real time as bio-feedback, while subjects are required to self-manipulate blood flow and electrophysiologic signals
  • EEG data were simultaneously recorded using a 64- channel Neuroscan MagLink System.
  • BOLD images were acquired during the two resting states of eyes closed (EC) and eyes open (EO) with a typical gradient echo EPI sequence [60 acquisitions, 25 slices, 4mm thk/interleave, TR: 3s (1.5s image acquisition and 1.5s interval), TE: 30 ms, FOV: 22x22cm , Matrix: 64x64].
  • Perfusion images were acquired during EC, EO and a mental calculation (MC) task of serial subtraction (eyes closed), using an amplitude-modulated continuous ASL technique [60 acquisitions, 12 slices, 6mm thk/1.5mm sp, TR: 5s (2s labeling, Is delay, 0.5s image acquisition and 1.5s interval), TE: 17 ms, FOV: 22x22cm 2 , Matrix: 64x64].
  • SCAN 4.5 Neurodecan
  • Perfusion fMRI data were analyzed by SPM99.
  • CBF cerebral blood flow
  • Fig. 3 illustrates the CBF differences between the three states overlaid on the mean

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

This invention relates to methods for concurrently recording electrophysiologic signal (EEG) and cerebral blood flow (CBF) signal from human brain. Specifically, the invention relates to methods for noninvasively assessing brain function.

Description

CONCURRENT ELECTROPHYSIOLOGIC AND CEREBRAL BLOOD FLOW
NEUROIMAGING
FIELD OF INVENTION
[0001] This invention is directed to methods for concurrently recording electrophysiologic signal (EEG) and cerebral blood flow (CBF) signal from human brain. Specifically, the invention relates to methods for noninvasively assessing brain function during a subject's sleep and its utility.
BACKGROUND OF THE INVENTION
[0002] Dynamic neuroimaging of brain function during sleep bears considerable importance in both neuroscientifϊc and clinical fields. For instance, slow wave sleep, characterized by high voltage Delta waves (<4Hz) in EEG, has been demonstrated to be critical for memory consolidation, brain plasticity, learning and recovery of synaptic potential. Brain function can be enhanced during slow wave sleep by applying transcranial electric currents and by sleep medications. Rapid-eye-movement (REM) sleep is commonly known to be associated with dream. To date, however, there has been a large knowledge gap regarding the dynamic changes of brain function across the sleep-wake cycle. Nuclear medicine methods, such as PET, have been the primary approach for mapping brain function during sleep. Once EEG markers of a sleep stage of interest is spotted by researcher, radioisotope (e.g., FDG) is injected into sleeping subjects and radioactivity is measured after a period allowing the tracer to be deposited into the brain (30min for 18FDG). Such approach is undesirable because of repeated exposure to radioactivity. The fixed acquisition time window (10-30mins) requires subjects' behavioral state remains relatively stable during the whole time period, which is not always satisfied.
[0003] The combination of EEG and functional magnetic resonance imaging (fMRI) offers the potential for multi-model neuroimaging with both high spatial and temporal resolution, which opens the window to a wide range of applications. For instance, simultaneous EEG and (blood- oxygen-level-dependent) BOLD fMRI have been successfully applied for seizure localization in epilepsy patients. However, concurrent EEG/BOLD fMRI cannot be directly applied for sleep research since BOLD fMRI is only able to image transient brain responses elicited by external stimuli and tasks. In addition, removal of the large artifact in EEG signal caused by rapid magnetic gradient switching in BOLD fMRI is challenging, especially performed in real time. Event-related potential (ERP) often has to be extracted from EEG for correlation with BOLD fMRI, whose magnitude is on the order of one tenth of the original EEG signal, adding further difficulty for signal processing.
[0004] Arterial spin labeling (ASL) perfusion MRI is a noninvasive neuroimaging technique that offers absolute quantification of CBF both at rest and during task activation. ASL is ideally suited for imaging sustained behavioral states due to its long term temporal stability. Concurrent recording of EEG and ASL perfusion fMRI provides several potential advantages. First, resting perfusion can be easily linked to EEG power spectrum during specific behavioral states without the need to perform task activation. Second, ASL scans include inherent magnetic gradient quiet periods (e.g., delay time) with reduced interferences for EEG recording, facilitating real-time noise removal. Third, EEG/ASL studies are less demanding in terms of signal processing, since ERP is generally not required. Finally, EEG/ASL data can be continuously recorded across various stages of the sleep-wake cycle with a temporal resolution of seconds in one scanning session. The acoustic noise level is also much lower in ASL than BOLD fMRI, which is a benefit for sleep neuroimaging.
[0005] Neuroimaging of sleep is well suited for concurrent EEG/ASL. Once reliable neuroimaging markers for various sleep stages are identified, the technique can be used for monitoring effects of pharmacological and behavioral manipulations on sleep. Ideally, because EEG and ASL perfusion MRI each provides unique markers for certain neurobiological processes, the fusion of the two technologies is expected to create more reliable neuroimaging markers than each technique alone. EEG/ASL is also expected to have wide applications outside sleep research, including assessing mental state/stress during continuous performance tasks, monitoring neurophysiological effects of drug candidates, and seizure localization etc.
SUMMARY OF THE INVENTION
[0006] In one embodiment, the invention provides a method of neuroimaging brain function of a subject during sleep, comprising the steps of: Concurrently recording electrophysiologic brain signals and cerebral blood flow (CBF) data of the sleeping subject; Reconstructing the cerebral blood flow (CBF) data within time window of interest based on a marker of electrophysiologic brain signals; and Dynamically associating the electrophysiologic brain signals and reconstructed cerebral blood flow (CBF) data, thereby neuroimaging brain function of the subject during sleep.
[0007] In another embodiment, provided herein is a method of diagnosing or providing prognosis of sleep disorders or both in a subject, comprising concurrently neuroimaging brain function of the subject during sleep using concurrent recording electrophysiologic brain signals and cerebral blood flow (CBF) data; comparing the data with a standard, whereby the standard is taken from a subject or pool of subject previously, correctly diagnosed as having the sleep disorder sought to be diagnosed or for which prognosis is given; and comparing the signals.
[0008] In one embodiment, the invention provides a method of screening an agent for effectiveness as a sleeping aid in a subject, comprising concurrently neuroimaging brain function of the subject during sleep using concurrent recording electrophysiologic brain signals and cerebral blood flow (CBF) data; comparing the data with a standard, whereby the standard is taken from a subject or pool of subject previously exposed to an effective, or ineffective sleeping medication; and comparing the signals.
[0009] In another embodiment, the invention provides a method of screening effects of stress on sleep in a subject, comprising concurrently neuroimaging brain function of the subject during sleep using concurrent recording electrophysiologic brain signals and cerebral blood flow (CBF) data; comparing the data with a standard, whereby the standard is taken from the subject before or after being exposed to the stress whose effect is sought to be screened.
[00010] Other features and advantages of the present invention will become apparent from the following detailed description examples and figures. It should be understood, however, that the detailed description and the specific examples while indicating preferred embodiments of the invention are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
BRIEF DESCRIPTION OF THE DRAWINGS
[00011] The invention will be better understood from a reading of the following detailed description taken in conjunction with the drawings in which like reference designators are used to designate like elements, and in which:
[00012] Figure 1 shows concurrent EEG/ASL feasibility study results showing increased
CBF in visual cortex during eyes open (EO) vs. eyes closed (EC) states. Increased EEG α power is observed in O1/O2 between EO and EC.
[00013] Figure 2 shows an embodiment of a system for concurrent fMRI and EEG. [00014] Figure 3 shows CBF activation differences between three states.
[00015] Figure 4 shows EEG spectral analysis of EC (red), EO (green), and MC (yellow) during BOLD fMRI and ASL fMRI scanning.
[00016] Figure 5 shows diagram of ASL pulse sequences which consist of spin labeling, post-labeling delay time, image acquisition and delay time (TD); also shown are associated acoustic noise level and interferences on EEG recording. The post-labeling delay and TD portions are silent periods in terms of magnetic gradient and acoustic noise, which do not interfere with EEG recording. The labeling period causes mild interferences and mild acoustic noise, while only the imaging acquisition part generates high interferences on EEG and a high acoustic noise level due to the use of rapid imaging sequences such as the echo-planar imaging (EPI).
DETAILED DESCRIPTION OF THE INVENTION
[00017] This invention relates in one embodiment to methods for concurrently recording electrophysiologic signal (EEG) and cerebral blood flow (CBF) signal from human brain. In another embodiment, the invention relates to methods for noninvasively assessing brain function using functional MRI and electroencephalograph (EEG).
[00018] In one embodiment, the method provided herein are used for neuroimaging of sleep.
In another embodiment, the methods provided herein are used for investigating the neurobiology of sleep along with the dynamic changes across the sleep-wake cycle. Clinical applications of the methods described herein, are diagnosis and prognosis of sleep disorders, or in another embodiment, testing central effects of sleep medications. In another embodiment, since both EEG and perfusion fMRI provide specific markers for work load, vigilance, stress and drug effects etc, the methods described herein are useful for monitoring continuous performance tasks, CNS responses to pharmacological manipulations, and bio-feedback training.
[00019] In another embodiment, combination of EEG and fMRI offers the potential for multi-model neuroimaging with both high spatial and temporal resolutions. Accordingly and in one embodiment, provided herein is a method of neuroimaging brain function of a subject during sleep, comprising the steps of: Concurrently recording electrophysiologic brain signals and cerebral blood flow (CBF) data of the sleeping subject; Reconstructing the cerebral blood flow (CBF) data within time window of interest based on a marker of electrophysiologic brain signals; and Dynamically associating the electrophysiologic brain signals and reconstructed cerebral blood flow (CBF) data, thereby neuroimaging brain function of the subject during sleep. In another embodiment, concurrent EEG and perfusion fMRI is used for tracking gradual state changes in brain function (e.g. sleep), with characteristic markers in both hemodynamics and neurophysiology.
[00020] In one embodiment, electrophysiologic brain signals are recorded using electroencephalography (EEG). An "electroencephalogram" or "EEG" refers in one embodiment, to an outward indication of electrical activity from the most superficial layers of the cerebral cortex, usually recorded from electrodes on the scalp. This activity is the result of the rhythmic discharging of neurons under the electrode. In another embodiment, the EEG signal provides information about the frequency and amplitude of the neuronal electrical activity and its temporal variation, or in another embodiment, of electrophysiologic brain signals. In one embodiment the EEG frequency spectrum comprises signals in a 2 to 80 Hz range, with most activity between about 2 and 15 Hz.
[00021] In one embodiment, there are two methods for analyzing the EEG, i.e., a linear analysis method such as a Fourier transform and a nonlinear analysis method such as a correlation dimension estimation. The Fourier transform can obtain the information for a specific frequency component such as α-wave (8-13 Hz) and β-wave (14-30 Hz) extensively studied. The correlation dimension estimation is used to determine whether or not EEG time series are chaos signals.
[00022] In one embodiment, a particular MRI technology, termed arterial spin labeling
(ASL) perfusion MRI, is used to measure dynamic variations in cerebral blood flow during sleep. In one embodiment, the term MRI refers to magnetic resonance imaging. Magnetic resonance imaging refers in one embodiment to a technique for magnetically exciting nuclear spins of a subject placed in a static magnetic field by applying a radio-frequency signal with the Larmor frequency, and obtaining images using FTD (free-induction decay) signals or echo signals induced with the excitation. One category of the magnetic resonance imaging is ASL (Arterial Spin Labeling) imaging. This imaging provides perfusion (tissue blood) images in which blood vessels and microcirculation of a subject are reflected, without injecting contrast medium into the subject, i.e., non-invasively. In one embodiment, the ASL method used in the methods described herein, includes a "continuous ASL (CASL) technique" or a "pulsed ASL (PASL) technique" or a "pseudo-continuous ASL technique". CASL technique refers in one embodiment, to a way of applying a largely continuous adiabatic RF wave, while in another embodiment, PASL technique refers to the application of a pulsed adiabatic RF wave that can easily be practiced by a clinical MRI system. In another embodiment, pseudo-continuous ASL technique refers to the application of a train of pulsed RF wave to simulate the effect of CASL.
[00023] In one embodiment, cerebral blood flow (CBF) is measured directly by using arterial blood water as an endogenous contrast agent. In one embodiment, perfusion MRI used in the methods as described herein, is ideal for imaging a sustained behavioral state, such as sleep in another embodiment with excellent reproducibility over long-term time periods and minimal sensitivity to magnetic-field inhomogeneity effects, that involves the function of deep brain structures.
[00024] In one embodiment, the brain regions used in the methods for tracking gradual state changes in brain function (e.g. sleep) with characteristic markers in both hemodynamics and neurophysiology a are the right prefrontal cortex (RPFC), left prefrontal cortex, orbitofrontal cortex, anterior cingulate cortex (ACC), insula, puteman, amygdala, striatum, nucleus accumbens (NA) and hippocampus or a combination thereof. In another embodiment, the prefrontal cortex, dorsal striatum, and medial temporal lobe are involved in task completion under condition of sleep deprivation and are the brain regions monitored using the methods provided herein.
[00025] In one embodiment, concurrent recording of EEG and ASL perfusion MRI involves the use of MRI compatible EEG systems during perfusion MRI scanning. In another embodiment, subjects wear an electrode cap made of non-magnetic material, and the EEG signal is conducted through fiberoptic cables or carbon fibers to amplifiers outside the MRI scan room. Amplified EEG signal is stored in one embodiment and displayed in real time in another embodiment, by a PC workstation.
[00026] In another embodiment, perfusion fMRI scanning utilizes ASL sequences
(including pulsed in one embodiment, or continuous and pseudo-continuous ASL in other embodiments, or their combination), which is comprised of four portions for spin labeling, post- labeling delay time, image acquisition and delay time. A relatively long repetition time (TR>4s) is used in one embodiment, to ensure at least 50% of scan time is free of magnetic gradient artifact. The ASL sequence transmits a TTL pulse every measurement (TR) to the EEG workstation to synchronize the data stream in two modalities. If real time analysis of ASL data is required in one embodiment, the acquired perfusion MRI series is transferred from the MR host computer to the EEG workstation through network links on the fly. [00027] For sleep research, the acoustic noise of ASL image acquisition can be further reduced by several approaches. These approaches include adjusting the gradient-readout frequency to avoid the resonance frequencies of gradient coil vibrations, the use of quite gradient coils and silent MR pulse sequences. Due to the relatively long scan time for sleep research, the ASL sequences can further correct head motion in real time by incorporating techniques such as prospective acquisition correction.
[00028] In one embodiment, physiological data that can be concurrently measured include heart rate, blood pressure, respiration rate, temperature, PaCO2, PaO2, and galvanic skin response (GSR).
[00029] In one embodiment, for the purpose of reconstruction of CBF data within time window of interest based on EEG markers, perfusion MRI series are loaded in one embodiment onto a common software platform together with EEG during post-processing or in real time in another embodiment. In one embodiment, MRI and EEG data are temporally aligned according to TTL markers. Initial MRI data processes include exclusion of spurious spikes in one embodiment, or motion correction and spatial smoothing or their combination in other embodiments. In another embodiment, the user defines the time window of interest by evaluating continuous EEG data (e.g., REM) in certain embodiments, or according to other pre-selected triggers. In another embodiment, mean quantitative CBF maps of the defined time window are automatically generated (using ASL perfusion models), displayed and stored for further analysis. The software is flexible enough to generate CBF maps for each time period, or to integrate over several discrete time windows, or to provide difference CBF maps between two periods. In another embodiment ASL data is acquired through the use specific EEG markers as trigger to initiate ASL perfusion MRI scanning.
[00030] In another embodiment, within the defined time window, dynamic association of
EEG and perfusion image series are carried out. In one embodiment, EEG power spectrum provides indices of slow and fast components (e.g. Delta vs. Beta) as a function of time, which are used in another embodiment as covariates in correlation analysis of the perfusion time series. In another embodiment, perfusion time series in specific brain regions are used as covariates in correlation analysis of the EEG time series.
[00031] In one embodiment, the step of reconstruction of CBF data within time window of interest based on EEG markers in the methods of neuroimaging brain function of a subject during sleep is preceded by a step of removing noise of EEG data in real time. In one embodiment, since >50% EEG is free of MRI artifact, EEG periods presenting gradient artifacts are masked. In another embodiment, the cardio-ballistic noise in EEG caused by involuntary subject movements is minimized by online regression with EKG signal. The processed EEG signals have sufficient quality in one embodiment, for spotting characteristic marks for behavioral states (e.g., Delta wave, K complexes for slow wave sleep). In one embodiment, online noise removal is performed to further reduce the gradient artifacts during MRI scanning. In another embodiment, reducing the gradient artifacts during MRI scanning according to the methods provided herein, requires pre- scanning to generate a template of time-locked gradient induced EEG artifact, followied by subtracting this noise template from real time EEG data using statistical methods, such as principle component analysis in one embodiment, or least-squares based fitting and cluster analysis in other embodiments.
[00032] In one embodiment, brain regions demonstrating CBF changes in ASL perfusion
MRI can be used as hypothesized foci of neural activation. Simulated EEG data based on these detected activation loci (seeds) can be generated and compared with the observed EEG signals, providing a means to validate the neural network model associated with a specific behavioral state. In another embodiment, both EEG and ASL data can be correlated with behavioral performance and physiological signals such as heart rate, blood pressure etc.
[00033] In one embodiment, the concurrently collected EEG/ASL data using the methods provided herein is displayed to subjects in real time as bio-feedback, while subjects are required to self-manipulate blood flow and electrophysiologic signals.
[00034] The term "subject" refers in one embodiment to a mammal including a human in need of therapy for, or susceptible to, a condition or its sequelae. The subject may include dogs, cats, pigs, cows, sheep, goats, horses, rats, and mice and humans. The term "subject" does not exclude an individual that is normal in all respects.
[00035] The following examples are presented in order to more fully illustrate the preferred embodiments of the invention. They should in no way be construed, however, as limiting the broad scope of the invention.
EXAMPLES
Materials and Methods: Concurrent recording of EEG and ASL perfusion MRl
[00036] This step involves the use of MRI compatible EEG systems during perfusion MRI scanning. Subjects wear an electrode cap made of non-magnetic material, and the EEG signal is conducted through fiberoptic cables or carbon fibers to amplifiers outside the MRI scan room. Amplified EEG signal is then stored and displayed in real time by a PC workstation. EEG sampling rate can be kept within 5kHz because of the low interference from ASL sequences.
Perfusion fMRI scanning utilizes ASL sequences (including pulsed, continuous and pseudo- continuous ASL), which generally comprise of three portions for spin labeling, delay time and image acquisition. A relatively long repetition time (TR>4s) is used to ensure at least 50% of scan time is free of magnetic gradient artifact. The ASL sequence transmits a TTL pulse every measurement (TR) to the EEG workstation to synchronize the data stream in two modalities. If real time analysis of ASL data is required, the acquired perfusion MRI series need to be transferred from the MR host computer to the EEG workstation through network links on the fly.
For sleep research, the acoustic noise of ASL image acquisition can be further reduced by several approaches. These approaches include adjusting the EPI-readout frequency to avoid the resonance frequencies of gradient coil vibrations, the use of quite gradient coils and silent MR pulse sequences. Due to the relatively long scan time for sleep research, the ASL sequences can further correct head motion in real time by incorporating techniques such as prospective acquisition correction. Additional physiological data that can be concurrently measured include heart rate, blood pressure, respiration rate, temperature, PaCO2, PaO2, and galvanic skin response (GSR).
Real time noise removal of EEG data
[00037] Because >50% EEG is free of MRI artifact, the simplest approach is just to mask out those EEG periods presenting gradient artifacts. The cardio-ballistic noise in EEG caused by involuntary subject movements is minimized by online regression with EKG signal. These processed EEG signals have sufficient quality for spotting characteristic marks for behavioral states (e.g., Delta wave, K complexes for slow wave sleep). If required, online noise removal can be performed to further reduce the gradient artifacts during MRI scanning. This step requires pre- scanning to generate a template of time-locked gradient induced EEG artifact, and then subtract this noise template from real time EEG data using principle component analysis or least-squares based fitting. Reconstruction of CBF data within time window of interest based on EEG markers
[00038] The perfusion MRI series are loaded onto a common software platform together with EEG during post-processing or in real time. The MRI and EEG data are temporally aligned according to TTL markers. Initial MRI data processes include exclusion of spurious spikes, motion correction and spatial smoothing. The user then can define the time window of interest by evaluating continuous EEG data (e.g., REM). Mean quantitative CBF maps of the defined time window can be automatically generated (using ASL perfusion models), displayed and stored for further analysis. The software is flexible enough to generate CBF maps for each time period, or to integrate over several discrete time windows, or to provide difference CBF maps between two periods. An alternative approach to acquire ASL data is to use specific EEG markers as trigger to initiate ASL perfusion MRI scanning.
Dynamic association of EEG and CBF data
Within the defined time window, dynamic association of EEG and perfusion image series can be further carried out. EEG power spectrum provides indices of slow and fast components (e.g. Delta vs. Beta) as a function of time, which are used as covariates in correlation analysis of the perfusion time series. Vice versa, perfusion time series in specific brain regions are used as covariates in correlation analysis of the EEG time series. Further, brain regions demonstrating CBF changes in ASL perfusion MRI can be used as hypothesized foci of neural activation. Simulated EEG data based on these detected activation loci (seeds) can be generated and compared with the observed EEG signals, providing a means to validate the neural network model associated with a specific behavioral state. Both EEG and ASL data can be correlated with behavioral performance and physiological signals such as heart rate, blood pressure etc.
Bio-feedback of real time EEG and CBF data (optional)
[00039] The EEG/ASL data can be displayed to subjects in real time as bio-feedback, while subjects are required to self-manipulate blood flow and electrophysiologic signals
Example 1:
[00040] Five subjects (4 male, age 23-27 years) were scanned on a Siemens 3.0T Trio scanner, using the standard volume head coil. EEG data were simultaneously recorded using a 64- channel Neuroscan MagLink System. BOLD images were acquired during the two resting states of eyes closed (EC) and eyes open (EO) with a typical gradient echo EPI sequence [60 acquisitions, 25 slices, 4mm thk/interleave, TR: 3s (1.5s image acquisition and 1.5s interval), TE: 30 ms, FOV: 22x22cm , Matrix: 64x64]. Perfusion images were acquired during EC, EO and a mental calculation (MC) task of serial subtraction (eyes closed), using an amplitude-modulated continuous ASL technique [60 acquisitions, 12 slices, 6mm thk/1.5mm sp, TR: 5s (2s labeling, Is delay, 0.5s image acquisition and 1.5s interval), TE: 17 ms, FOV: 22x22cm2, Matrix: 64x64]. SCAN 4.5 (Neuroscan) was used to analyze the interleaved EEG data recorded during the scan interval of BOLD fMRI and during the delay time of CASL perfusion fMRI, during which no EPI induced noise was present. Perfusion fMRI data were analyzed by SPM99. For each subject, raw EPI images were corrected for head motion, followed by pair-wise subtraction of label and control acquisitions and conversion to quantitative cerebral blood flow (CBF) images based on the single- compartment perfusion model. Voxel-vise population comparisons were then conducted on CBF images. Areas of significant activation were identified for uncorrected P value smaller than 0.05 and cluster size larger than 30 voxels (voxel size 2x2x2 mm3).
[00041 ] Fig. 3 illustrates the CBF differences between the three states overlaid on the mean
CBF images from all five subjects. High quality perfusion images were obtained in each subject, with a mean global CBF value of 43.6 ml/100g/min. Consistent with the neuroimaging literature, perfusion fMRI revealed greater visual activation for EO than EC, and greater frontal and parietal activations for MC than EC. Fig. 4 illustrates the differences between the three states from EEG spectral analysis. Consistent with the EEG literature, EEG revealed greater alpha component (8- 1 IHz) in posterior brain for EC than EO, greater delta (1-3.5Hz) and theta components (3.5-6Hz) in frontal areas for MC than EC
[00042] Having described preferred embodiments of the invention with reference to the accompanying drawings, it is to be understood that the invention is not limited to the precise embodiments, and that various changes and modifications may be effected therein by those skilled in the art without departing from the scope or spirit of the invention as defined in the appended claims.

Claims

What is claimed is:
1. A method of neuroimaging brain function of a subject during sleep, comprising the steps of:
a. Concurrently recording electrophysiologic brain signals and cerebral blood flow (CBF) data of the sleeping subject;
b. Reconstructing the cerebral blood flow (CBF) data within time window of interest based on a marker of electrophysiologic brain signals; and
c. Dynamically associating the electrophysiologic brain signals and reconstructed cerebral blood flow (CBF) data, thereby neuroimaging brain function of the subject during sleep
2. The method of claim 1, whereby recording electrophysiologic brain signals is carried out using an electroencephalography. (EEG)
3. The method of claim 1, whereby recording cerebral blood flow (CBF) data is carried out using perfusion magnetic resonance imaging (MRI) scanning.
4. The method of claim 3, whereby perfusion magnetic resonance imaging (MRI) scanning utilizes an arterial spin labeling (ASL) sequence.
5. The method of claim 4, whereby the arterial spin labeling (ASL) sequence is pulsed, continuous, pseudo-continuous ASL, or a combination thereof.
6. The method of claim 2, whereby the step of reconstructing is preceded by a step of removing noise of EEG data in real time.
7. The method of claim 2, whereby the step of reconstructing the cerebral blood flow (CBF) data within time window of interest comprises aligning the cerebral blood flow (CBF) data and electrophysiologic brain signals according to a transistor-transistor-logic (TTL) marker, wherein the TTL marker is generated by the MRI system and captured by EEG.
PCT/US2008/005815 2007-05-07 2008-05-07 Concurrent electrophysiologic and cerebral blood flow neuroimaging WO2008137161A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92428307P 2007-05-07 2007-05-07
US60/924,283 2007-05-07

Publications (2)

Publication Number Publication Date
WO2008137161A2 true WO2008137161A2 (en) 2008-11-13
WO2008137161A3 WO2008137161A3 (en) 2009-12-30

Family

ID=39944176

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/005815 WO2008137161A2 (en) 2007-05-07 2008-05-07 Concurrent electrophysiologic and cerebral blood flow neuroimaging

Country Status (1)

Country Link
WO (1) WO2008137161A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104545895A (en) * 2014-09-22 2015-04-29 中国科学院昆明动物研究所 Method for quickly screening out drug addicts by electroencephalogram characteristics
CN104887252A (en) * 2015-06-12 2015-09-09 郝英霞 Mental disease detection device
CN105011943A (en) * 2015-07-14 2015-11-04 山东师范大学 Rat behavior infrared identification system, using method and application thereof
EP2918222A4 (en) * 2013-11-15 2016-11-02 Yibing Wu Life maintenance mode, brain inhibition method and personal health information platform
WO2020210813A1 (en) * 2019-04-11 2020-10-15 The General Hospital Corporation Generating imaging-based neurological state biomarkers and estimating cerebrospinal fluid (csf) dynamics based on coupled neural and csf oscillations during sleep

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6717405B2 (en) * 2002-04-12 2004-04-06 Beth Israel Deaconess Medical Center, Inc. Arterial spin labeling using time varying gradients
US20040097802A1 (en) * 2000-08-15 2004-05-20 Cohen Mark S Method and apparatus for reducing contamination of an electrical signal

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040097802A1 (en) * 2000-08-15 2004-05-20 Cohen Mark S Method and apparatus for reducing contamination of an electrical signal
US6717405B2 (en) * 2002-04-12 2004-04-06 Beth Israel Deaconess Medical Center, Inc. Arterial spin labeling using time varying gradients

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2918222A4 (en) * 2013-11-15 2016-11-02 Yibing Wu Life maintenance mode, brain inhibition method and personal health information platform
CN104545895A (en) * 2014-09-22 2015-04-29 中国科学院昆明动物研究所 Method for quickly screening out drug addicts by electroencephalogram characteristics
CN104545895B (en) * 2014-09-22 2017-02-01 中国科学院昆明动物研究所 Method for quickly screening out drug addicts by electroencephalogram characteristics
CN104887252A (en) * 2015-06-12 2015-09-09 郝英霞 Mental disease detection device
CN105011943A (en) * 2015-07-14 2015-11-04 山东师范大学 Rat behavior infrared identification system, using method and application thereof
WO2020210813A1 (en) * 2019-04-11 2020-10-15 The General Hospital Corporation Generating imaging-based neurological state biomarkers and estimating cerebrospinal fluid (csf) dynamics based on coupled neural and csf oscillations during sleep

Also Published As

Publication number Publication date
WO2008137161A3 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
Liao et al. Endless fluctuations: temporal dynamics of the amplitude of low frequency fluctuations
He et al. Multimodal functional neuroimaging: integrating functional MRI and EEG/MEG
Steele et al. Neuroimaging measures of error-processing: Extracting reliable signals from event-related potentials and functional magnetic resonance imaging
Laufs et al. Recent advances in recording electrophysiological data simultaneously with magnetic resonance imaging
Brown et al. Brain development during the preschool years
Beer et al. Combined diffusion-weighted and functional magnetic resonance imaging reveals a temporal-occipital network involved in auditory-visual object processing
Rosenkranz et al. Present and future of simultaneous EEG-fMRI
Moeller et al. Representation and propagation of epileptic activity in absences and generalized photoparoxysmal responses
US20090163798A1 (en) Apparatus and method for detection and monitoring of electrical activity and motion in the presence of a magnetic field
US20110301448A1 (en) Methods for measurement of magnetic resonance signal perturbations
Balderston et al. Threat of shock increases excitability and connectivity of the intraparietal sulcus
Stern et al. Advances in functional neuroimaging methodology for the study of brain systems underlying human neuropsychological function and dysfunction
Wang et al. Concordance of MEG and fMRI patterns in adolescents during verb generation
Ebrahimzadeh et al. Simultaneous electroencephalography-functional magnetic resonance imaging for assessment of human brain function
WO2008137161A2 (en) Concurrent electrophysiologic and cerebral blood flow neuroimaging
Comi et al. Visual evoked potentials may be recorded simultaneously with fMRI scanning: a validation study
Cetin et al. Multimodal based classification of schizophrenia patients
Bhattacharyya et al. A review on brain imaging techniques for BCI applications
Chen et al. Electrophysiological resting state brain network and episodic memory in healthy aging adults
Mirsattari et al. Linear aspects of transformation from interictal epileptic discharges to BOLD fMRI signals in an animal model of occipital epilepsy
Motelow et al. Functional neuroimaging of spike-wave seizures
Savoy Functional magnetic resonance imaging (fMRI)
KR102174092B1 (en) Method for direct monitoring and spatial mapping of neuronal activity
Poudel et al. Multimodal Neuroimaging with Simultaneous fMRI and EEG
Duru et al. Investigaton of the neuronal efficacy and EEG source power under steady-state visual stimulation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08767600

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08767600

Country of ref document: EP

Kind code of ref document: A2